¿Es el PCA3 costoefectivo en Latinoamérica y el Caribe? / Is the PCA3 cost-effective in Latin America and the Caribbean?
Salud pública Méx
; 60(1): 104-105, Jan.-Feb. 2018.
Article
in Es
| LILACS
| ID: biblio-903864
Responsible library:
BR1.1
Full text:
1
Index:
LILACS
Main subject:
Prostatic Neoplasms
/
Adenocarcinoma
/
Biomarkers, Tumor
/
Early Detection of Cancer
/
Antigens, Neoplasm
/
Neoplasm Proteins
Type of study:
Diagnostic_studies
/
Health_economic_evaluation
/
Screening_studies
Limits:
Humans
/
Male
Language:
Es
Journal:
Salud pública Méx
Journal subject:
SAUDE PUBLICA
Year:
2018
Type:
Article